Drug-drug liver injury in patients NAFLD with COVID-19

被引：0
|
作者：
Pavlov, A. [1 ]
Karakozov, A. [2 ]
Molodova, A. [2 ]
Denisova, O. [3 ,4 ]
Kazakov, S. [3 ,4 ]
机构：
[1] AA Vishnevsky Natl Med Res Ctr High Med Technol, Moscow, Russia
[2] Russian Univ Med, Minist Hlth Russian Federat, Fed State Budgetary Educ Inst Higher Educ, Moscow, Russia
[3] Fed Med & Biol Agcy Russia, Fed State Budgetary Inst, Fed Sci & Clin Ctr Specialized Types Med Care & M, Moscow, Russia
[4] Russian Assoc Med Lab Diagnost, Moscow, Russia
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.119231
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P1269
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [41] Drug-induced liver injury and COVID-19: A review for clinical practice
    Ortiz, Gabriela Xavier
    Lenhart, Gabriele
    Becker, Matheus William
    Schwambach, Karin Hepp
    Tovo, Cristiane Valle
    Blatt, Carine Raquel
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (09) : 1143 - 1153
  • [42] Physicians' knowledge of potential covid-19 drug-drug interactions: An online survey in turkey
    Surmelioglu, Nursel
    Yalcin, Nadir
    Kuscu, Ferit
    Candevir, Aslihan
    Inal, Ayse Seza
    Komur, Suheyla
    Kurtaran, Behice
    Demirkan, Kutay
    Tasova, Yesim
    POSTGRADUATE MEDICINE, 2021, 133 (02) : 237 - 241
  • [43] Potential clinically significant drug-drug interactions of hydroxychloroquine used in the treatment of COVID-19
    Biswas, Mohitosh
    Roy, Debendra Nath
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (11)
  • [44] Evaluation of the Potential Drug-Drug Interactions among Hospitalized Patients with COVID-19: A Cross-Sectional Study
    Ozdamar, Emine Nur
    Sahtiyanci, Berrak
    GAZI MEDICAL JOURNAL, 2023, 34 (03): : 295 - 300
  • [45] Drug-induced liver injury and COVID-19: A review for clinical practice
    Gabriela Xavier Ortiz
    Gabriele Lenhart
    Matheus William Becker
    Karin Hepp Schwambach
    Cristiane Valle Tovo
    Carine Raquel Blatt
    World Journal of Hepatology, 2021, (09) : 1143 - 1153
  • [46] Risks of potential drug-drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience
    Cattaneo, D.
    Pasina, L.
    Conti, F.
    Giacomelli, A.
    Oreni, L.
    Pezzati, L.
    Bonazzetti, C.
    Piscaglia, M.
    Carrozzo, G.
    Antinori, S.
    Gervasoni, C.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (12) : 2849 - 2851
  • [47] Pharmacist's role in the management of drug-drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients
    Cordero, Carlos Guzman
    de Vicente, Maria Saez-Torres
    Espinosa, Alvaro Jimenez
    Sanchez, Ana Isabel Gago
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [48] The therapeutic landscape for COVID-19 and post-COVID-19 medications from genetic profiling of the Vietnamese population and a predictive model of drug-drug interaction for comorbid COVID-19 patients
    Nguyen, Thien Khac
    Vu, Giang Minh
    Duong, Vinh Chi
    Pham, Thang Luong
    Nguyen, Nguyen Thanh
    Tran, Trang Thi Ha
    Tran, Mai Hoang
    Nguyen, Duong Thuy
    Vo, Nam S.
    Phung, Huong Thanh
    Hoang, Tham Hong
    HELIYON, 2024, 10 (06)
  • [49] Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor
    Huang, Jingjing
    Zhang, Zhaokang
    Hao, Chenxia
    Qiu, Yuzhen
    Tan, Ruoming
    Liu, Jialin
    Wang, Xiaoli
    Yang, Wanhua
    Qu, Hongping
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [50] Drug–Drug Interactions in Patients with COVID-19 in Nursing Homes
    Florian Correard
    Anne-Laure Couderc
    Robin Arcani
    Joris Weiland
    Anais Courcier
    Charlotte Berard
    Charlène Miola
    Julie Berbis
    Patrick Villani
    Aurélie Daumas
    Drugs & Aging, 2021, 38 : 633 - 635
12345